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2/M checkpoints prevent mitotic entry upon
DNA damage or replication inhibition by tar-
geting the Cdc2 regulators Cdc25 and Wee1.
Although Wee1 protein stability is regulated by DNA-
responsive checkpoints, the vertebrate pathways control-
ling Wee1 degradation have not been elucidated. In
budding yeast, stability of the Wee1 homologue, Swe1,
is controlled by a regulatory module consisting of the
proteins Hsl1 and Hsl7 (histone synthetic lethal 1 and 7),
which are targeted by the morphogenesis checkpoint to
prevent Swe1 degradation when budding is inhibited.
We report here the identiﬁcation of 
 
Xenopus
 
 Hsl7 as a
G
 
positive regulator of mitosis that is controlled, instead,
by an entirely distinct checkpoint, the DNA replication
checkpoint. Although inhibiting Hsl7 delayed mitosis,
Hsl7 overexpression overrode the replication check-
point, accelerating Wee1 destruction. Replication check-
point activation disrupted Hsl7–Wee1 interactions, but
binding was restored by active polo-like kinase. These
data establish Hsl7 as a component of the replication
checkpoint and reveal that similar cell cycle control
modules can be co-opted for use by distinct checkpoints
in different organsims.
 
Introduction
 
Entry into mitosis in all eukaryotic cells is controlled by the
Cdc2 (cell division control protein 2)–cyclin B kinase complex.
Activation of this complex is restrained in the presence of dam-
aged or incompletely replicated DNA by checkpoint pathways
that act to maintain inhibitory phosphorylations of Cdc2 on Thr
14 and Tyr 15 (Elledge, 1996; Lew and Kornbluth, 1996).
These sites are phosphorylated by related kinases, Wee1 and
Myt1, and are dephosphorylated by the Cdc25 phosphatase.
Accordingly, checkpoint pathways act to inhibit Cdc25 func-
tion and ensure the continued Cdc2-suppressive activity of
Wee1 (and possibly Myt1). Recently, it has been reported that
Wee1 protein stability is controlled by DNA-responsive check-
point pathways in extracts prepared from 
 
Xenopus
 
 eggs. In-
triguingly, it was found that Wee1 is stabilized during DNA
replication (or following DNA damage) and that it is degraded
within nuclei at the time of mitotic entry (Michael and New-
port, 1998). In 
 
Xenopus laevis
 
 it has been reported that Wee1
ubiquitination and proteasomal degradation are driven by a
Skp1–cullin–F box (SCF) E3 ligase complex containing a
novel F-box protein, Tome-1 (trigger of mitotic entry; Ayad et
al., 2003). Human Wee1A, however, is reportedly ubiquiti-
nated by an SCF complex containing 
 
 
 
-TrCP (
 
 
 
 transducin
repeat containing protein; Watanabe et al., 2004). This difference
may reflect either species differences or the fact that an embry-
onic form of Wee1 was studied in 
 
Xenopus
 
 whereas a somatic
form of Wee1 was analyzed in human cells. Other vertebrate
factors responsible for promoting Wee1 degradation or linking
it to DNA-responsive checkpoints have not yet been identified.
In the yeast 
 
Saccharomyces cerevisiae
 
, the stability of the
Wee1 homologue, Swe1 is under the control of a checkpoint
pathway monitoring budding and the status of the actin cyto-
skeleton (the morphogenesis checkpoint; Sia et al., 1996). This
checkpoint is thought to prevent mitotic entry, at least in part,
through stabilization of Swe1 (Sia et al., 1998). Looking to this
system for candidate Wee1 regulators, we were struck by the
requirement for an evolutionarily conserved methyltransferase,
Hsl7 (histone synthetic lethal 7), in promoting Wee1 degrada-
tion. The morphogenesis checkpoint regulates interaction of
Hsl7 with an associated kinase, Hsl1, to prevent Swe1 degrada-
tion. Consistent with these observations, overexpression of
Hsl7 can override the morphogenesis checkpoint, allowing mitotic
entry even when budding is inhibited (McMillan et al., 1999).
These data place 
 
S. cerevisiae
 
 Hsl7 as a central regulator of
Swe1 protein stability. In contrast, the Hsl7 homologue (Skb1)
in the fission yeast, 
 
Schizosaccharomyces pombe
 
, appears to
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have a cell cycle role diametrically opposed to that of 
 
S. cerevi-
siae
 
 Hsl7. Specifically, Skb1 has been reported to inhibit,
rather than promote, mitotic entry through direct binding to the
mitotic Cdc2–cyclin complex (Gilbreth et al., 1998). In addi-
tion to its activity in cell cycle regulation, Skb1 has been re-
ported to regulate morphogenesis (in association with a PAK
family kinase) and to be involved in the hyperosmotic stress
response, which stimulates Skb1 methyltransferase activity (Yang
et al., 1999; Bao et al., 2001).
Although Hsl7 homologues have been reported in verte-
brates, including humans, analyses of their potential role
(stimulatory or inhibitory) in controlling mitotic entry has
been hampered by a potentially distinct requirement for verte-
brate Hsl7 as a component of the methylosome regulating
mRNA splicing (Friesen et al., 2001). Therefore, to analyze
Hsl7 cell cycle function we turned to the 
 
Xenopus
 
 egg extract,
which can undergo multiple cell cycles in vitro without any
de novo mRNA transcription, allowing an analysis of cell cy-
cle regulation in a system free of confounding effects on
mRNA processing (Friesen et al., 2001). We report here that
 
Xenopus
 
 Hsl7 controls entry into M phase by controlling the
intranuclear stability of Wee1. Moreover, just as overproduc-
tion of Hsl7 can override the morphogenesis checkpoint in
budding yeast, overproduction of 
 
Xenopus
 
 Hsl7 can short-cir-
cuit the DNA replication checkpoint, allowing mitotic entry
in the presence of incompletely replicated DNA. These data
strongly suggest that the Hsl7–Wee1 cell cycle control mod-
ule can be used for controlling entry into mitosis in verte-
brates, as well as in 
 
S. cerevisiae
 
, but that this module has
been co-opted by vertebrates to respond to a different check-
point signal than in yeast.
 
Results
 
Identification of 
 
Xenopus
 
 Hsl7
 
To identify potential 
 
Xenopus
 
 Hsl7 homologues, we searched
the Washington University 
 
Xenopus
 
 EST database, and iden-
tified five Hsl7-related EST clones of various lengths. After
DNA sequencing, we identified a full-length 
 
Xenopus
 
 Hsl7
cDNA (hereafter referred to as xHsl7) bearing 26% identity/
44% similarity to yeast Hsl7 and 83% identity/92% similar-
ity to human Hsl7 (known as JBP1 [Janus kinase binding
protein 1]/PRMT5; Genbank/EMBL/DDBJ accession no.
AY535008) (Fig. 1). We were further encouraged to pursue
analysis of this clone as we found that recombinant 
 
S. cerevi-
siae
 
 Hsl7 protein readily bound 
 
Xenopus
 
 Wee1 in egg
extracts (Fig. 2 A). This suggested that the Hsl7–Wee1 inter-
action might be conserved and that the 
 
Xenopus
 
 protein
might also play a role in regulating Wee1 function and mi-
totic entry.
 
Overexpression of xHsl7 accelerates 
entry into mitosis
 
As a first step in evaluating xHsl7 function, we wished to
overexpress xHsl7 in cycling extracts of 
 
Xenopus
 
 eggs, which
are able to oscillate between S and M phases of the cell cycle.
For this purpose, we supplemented translationally competent
(though transcriptionally inactive) cycling egg extracts with
Figure 1. Amino acid sequence alignment of
Xenopus, human and yeast Hsl7 proteins. The
amino acid sequences of Hsl7 orthologs were
aligned using the ClustalW alignment parame-
ters in the program MacVector. Dark shading
indicates identities and light shading indicates
similarities. 
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excess mRNA encoding xHsl7, allowing production of xHsl7
to levels approximately twofold that found endogenously (un-
published data). Under these conditions, we found that excess
xHsl7 could markedly accelerate entry into mitosis, as shown
by both microscopic monitoring of nuclear envelope break-
down and assays of histone H1-directed Cdc2 kinase activity
(Fig. 2 B). Interestingly, this acceleration was absent in ex-
tracts that had not been supplemented with nuclei, suggesting
that the effects of xHsl7 on the cell cycle were nuclear depen-
dent (Fig. 2 C). (Note that the extract shown here is distinct
from the one used in Fig. 2 B. In this and subsequent figures,
the absolute timing of mitosis differed from extract to extract,
but the relative rates of mitotic entry under different treatment
conditions remained constant.) The different response of ex-
tracts containing or lacking nuclei to xHsl7 addition did not
reflect any differences in the intrinsic stability of xHsl7 pro-
tein under these conditions, since xHsl7 was equally stable in
the presence and absence of nuclei (Fig. 2 D). In addition, an
xHsl7 mutant altered at well-conserved residues required for
protein methyltransferase activity was as potent as wild type
in accelerating mitotic entry, consistent with recent reports
that methyltransferase activity is dispensable for Hsl7-medi-
ated cell cycle regulation in 
 
S. cerevisiae
 
 (unpublished data;
Ma, 2000; Theesfeld et al., 2003).
 
Depletion or inhibition of Hsl7 delays the 
entry into mitosis
 
Using a commercially available antibody directed against the
human Hsl7 homologue, JBP1, we were readily able to detect
endogenous xHsl7 (Fig. 3 A). Moreover, this antibody could
detect xHsl7 co-immunoprecipitated with endogenous Wee1
(Fig. 3 B). This interaction was further confirmed by retrieval
of Wee1 from egg extracts by recombinant GST–xHsl7 linked
to glutatione sepharose (Fig. 3 C). These data suggested that
xHsl7 could positively regulate mitotic entry, perhaps through
an interaction with Wee1. Given these data, we wished to as-
sess the consequences of xHsl7 removal or inactivation on en-
try into mitosis. Therefore, we used Hsl7 antibodies to immu-
nodeplete xHsl7 from cycling extracts. As shown in Fig. 4 A,
extracts depleted with control IgG underwent two rounds of
mitosis, as measured by peaks of histone H1-directed kinase
activity, whereas extracts depleted of xHsl7 were entirely
blocked in their ability to enter mitosis. To examine the role of
xHsl7 using another approach, we added anti-Hsl7 antibodies
directly to cycling extracts with the goal of interfering with
xHsl7 function. Consistent with a role for xHsl7 in promoting
mitotic entry, we found that addition of purified anti-Hsl7 anti-
bodies, but not control IgG, to cycling egg extracts was able to
significantly delay entry into mitosis as measured by histone
H1-directed kinase activity assays and microsocopic observa-
tion of chromsome condensation/nuclear envelope breakdown
(Fig. 4, B and C). Moreover, readdition of recombinant xHsl7
restored the normal timing of mitotic entry, demonstrating that
the effects of the anti-Hsl7 antibody were specific (Fig. 4, B
and C). These data suggest that xHsl7 is required for efficient
entry into M phase in 
 
Xenopus
 
.
 
Wee1 is required for the cell cycle 
effects of xHsl7
 
Given the ability of xHsl7 to bind Wee1, we wished to deter-
mine whether the effect of xHsl7 overexpression on mitotic
entry was Wee1 mediated. Initially, we found that immunode-
pletion of Wee1 or addition of excess xHsl7 produced similar
accelerations in mitotic entry (unpublished data). These data
precluded an experiment in egg extracts to determine whether
xHsl7 could accelerate mitotic entry in the absence of Wee1,
as the kinetics of cyclin B accumulation in the cycling extract
make it difficult to observe cell cycle accelerations greater
Figure 2. Excess xHsl7 accelerates entry into mitosis in a nuclear-dependent
manner. (A) GST-yeast Hsl7 (lane1) or GST (lane 2) were incubated in
Xenopus egg extracts, retrieved on glutathione Sepharose, and immuno-
blotted with anti-Wee1 antibodies. (B) xHsl7-encoding mRNA or buffer was
incubated in cycling extracts with sperm nuclei (5,000/ l) and an ATP-
regenerating system. Aliquots were stored at the indicated times and assayed
for their ability to phosphorylate histone H1 in the presence of [
32P]ATP.
Phosphorylated histone was resolved by SDS-PAGE, subjected to autora-
diography, and quantified by phosphoimager with the zero time point nor-
malized to 1. Square, buffer; circle, FLAG-xHsl7 mRNA addition. Arrows
indicate the time of the nuclear envelope break down and the chromosome
condensation as monitored by microscope. (C) Same assay as panel B ex-
cept that sperm nuclei were absent. (D) In vitro–translated 
35S radiolabeled
xHsl7 and nucleoplasmin (as an internal control) were added to cycling ex-
tracts with or without nuclei present. Samples were withdrawn at the indi-
cated times, resolved by SDS-PAGE, and subjected to autoradiography to
monitor xHsl7 stability. Mitosis was observed at 90 min by fluorescence
microscopy of extracts containing Hoechst-stained nuclei.
Figure 3. Xenopus Hsl7 interacts with Wee1 in
Xenopus egg extracts. (A) HeLa cell lysate (10
 l), Xenopus egg extracts (2  l), or GST-xHsl7
were resolved by SDS-PAGE and immunoblotted
with anti-JBP1. (B) Immunoprecipitates formed
using affinity-purified anti-Wee1 or control IgG
were immunoblotted with anti-JBP1. (C) GST or
GST-xHsl7 coupled to glutathione Sepharose
was incubated in Xenopus egg extract and im-
munoblotted with anti-xWee1. 
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than those seen with depletion of Wee1 alone. Consequently,
to determine if xHsl7 effects were Wee1 mediated, we took
advantage of the fact that G2-arrested stage VI 
 
Xenopus
 
 oo-
cytes, which contain endogenous xHsl7 at levels similar to
that found in egg extracts, lack endogenous Wee1 (Nakajo et
al., 2000). Oocytes were injected with mRNA for the overex-
pression of FLAG-tagged xHsl7 and then treated with proges-
terone, which stimulates entry into M phase, as monitored
by breakdown of the nuclear envelope, or germinal vesicle
breakdown (GVBD). As shown in Fig. 5 A, when compared
with injection of control 
 
 
 
-globin mRNA, xHsl7 mRNA in-
jection produced no acceleration in progesterone-induced
GVBD. However, when we introduced mRNA encoding
 
Xenopus
 
 Wee1 into oocytes, we observed an inhibition of
GVBD, likely to due tyrosine phosphorylation of stock-
piled Cdc2–cyclin B complexes. This Wee1-induced delay in
GVBD could be almost entirely reversed by production of ex-
cess xHsl7 (Fig. 5 A), demonstrating that xHsl7 can regulate
M phase progression in the oocyte milieu, but only in the
presence of Wee1.
To assess the effects of xHsl7 on Cdc2-directed Wee1
kinase activity, we took interphase 
 
Xenopus
 
 cytosol (lacking
membranes and thus devoid of Myt1) as a source of robust
Wee1 kinase activity and either immunodepleted endogenous
xHsl7 or supplemented the extract with excess recombinant
xHsl7 (which, like excess xHsl7 RNA, was able to accelerate
mitotic entry in cycling extracts). The treated cytosols were
then incubated for 10 min at room temperature with recombi-
nant cyclin B1, sodium orthovanadate (to inhibit Cdc25), and
an ATP-regenerating mixture. Using anti-phospho Tyr 15 an-
tibodies to immunoblot these samples, we found that none of
the treatments markedly altered Wee1-mediated Cdc2 phos-
phorylation (Fig. 5 B). These data, taken together with previ-
ous observations on 
 
S. cerevisiae
 
 Hsl7, suggested the possi-
bility that xHsl7 might regulate Wee1 protein turnover, rather
than its activity.
 
Hsl7 promotes nuclear Wee1 
degradation
 
It has been reported that the DNA replication checkpoint sta-
bilizes Wee1 within nuclei, where it would otherwise be de-
graded at the time of mitotic entry (Michael and Newport,
1998). In examining xHsl7-mediated Wee1 degradation in
oocytes injected with both excess xHsl7 mRNA and radiola-
Figure 4. Blocking xHls7 function delays mitotic entry. (A) Cycling extracts
were depleted with antibodies directed against xHsl7 (square) or with
control mouse IgG (circle). Depleted extracts were incubated at room tem-
perature with sperm chromatin and an ATP-regenerating system, and cell
cycle progression was monitored by measuring Histone H1-directed kinase
activity, beginning at 60 min when both extracts were still in interphase,
as detected by fluorescence microscopy of Hoechst-stained nuclei. (B)
Control IgG (closed circle), anti-Hsl7 (closed square), or anti-Hsl7 supple-
mented with recombinant xHsl7 (open triangle) was incubated in 100  l
of cycling extract supplemented with sperm nuclei and ATP-regenerating
system. Experimental analysis was identical to Fig. 2 B. (C) Hoechst staining
of DNA was monitored by fluorescence microscopy to visualize nuclear
envelope breakdown and chromatin condensation.
Figure 5. Excess xHsl7 restores inhibition of oocyte maturation induced
by Wee1 injection and xHsl7 does not affect Wee1 kinase activity. (A) 50
stage VI oocytes were injected with 40 ng of mRNAs encoding  -globin
(open square), FLAG-xHsl7 (open circle), HA-Wee1 (closed square), and
40 ng each of FLAG-xHsl7 and HA-Wee1 mRNAs together (closed circle).
After a 12-h incubation, they were treated with progesterone and scored
for the percentage of GVBD. (B) Ultra S Xenopus egg extract (purified cy-
tosol) was either mock depleted, depleted of xHsl7, or supplemented with
recombinant xHsl7. ATP-regenerating system was then added along with
sodium vanadate to inhibit dephosphorylation of Cdc2. Recombinant hu-
man cyclin B1 was then added and the reaction was allowed to proceed
for 10 min. xWee1 activity was determined by assaying the phosphoryla-
tion level of Cdc2 by immunoblotting with anti-phospo Cdc2. 
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beled in vitro translated Wee1, we noted that xHsl7 over-
production promoted specific loss of the nuclear Wee1, as
detected by SDS-PAGE and autoradiography of manually
dissected oocyte nuclei (Fig. 6 A; nuclear envelope break-
down was prevented by addition of the Cdc2 inhibitor rosco-
vitine). Although Wee1 was also lost from the cytoplasm dur-
ing these experiments, this loss was not stimulated by xHsl7
overproduction. Moreover, since Wee1 is rapidly transported
into oocyte nuclei, we suspect that much of the loss of cyto-
plasmic Wee1 reflects nuclear import (unpublished data). As
in 
 
S. cerevisiae
 
, xHsl7-stimulated loss of Wee1 was not abro-
gated by disruption of the well-conserved residues responsi-
ble for methyltransferase activity (Fig. 6 B), nor was it in-
hibited by leptomycin B treatment to stop Crm1-mediated
nuclear export (Fig. 6 C; note the increase in nuclear Wee1 in
control injections due to inhibition of nuclear export. 
 
Xenopus
 
Hsl7 injection counteracts even the added burden of imported
Wee1 that cannot be exported). These data are consistent
with data reported previously suggesting intranuclear Wee1
degradation, particularly as nuclear export of Swe1 depends
on the Crm1 homologue, Expo1 (Lew, D.J., personal
communication).
Given our data suggesting that xHsl7 promoted Wee1
degradation, we wished to determine if the observed ability of
xHsl7 to reverse the Wee1-mediated delay in oocyte matura-
tion could potentially be accounted for by accelerated proteaso-
mal degradation of Wee1. To determine if this was the case, we
treated oocytes with the proteasome inhibitor MG132 and re-
peated the experiment shown in Fig. 5 A. We found not only
that the inhibitory effect of Wee1 on oocyte maturation was
more pronounced in the presence of MG132 (consistent with a
role for the proteasome in controlling Wee1 function), but that
xHsl7 was unable to counteract the effects of Wee1 in the ab-
sence of proteasome activity (Fig. 6 D). Taken together with
the observed effects of xHsl7 on nuclear Wee1 levels, these
data suggest that xHsl7 antagonizes Wee1 by promoting its
proteasomal degradation.
One important feature of xHsl7-stimulated nuclear Wee1
degradation in oocytes was its dependence upon progesterone
treatment, suggesting that M phase–promoting factors were
required for Wee1 degradation (such factors must be distinct
from Cdc2–cyclin B, as these experiments were performed in
the presence of roscovitine; unpublished data). Interestingly,
Wee1 exhibited a noticeable electrophoretic shift within the
nuclear, but not cytoplasmic, fraction before degradation,
which may reflect phosphorylation by kinases active at G2/M
(Fig. 6 A). It is also of interest to note that xHsl7 and Wee1
were unable to interact in 
 
Xenopus
 
 egg extracts lacking nu-
clei, consistent with an intranuclear locus of xHsl7 action
(Fig. 6 E); we have also found that xHsl7 is efficiently trans-
ported into nuclei (unpublished data). These data suggest
either that xHsl7 and Wee1 do not achieve sufficient concen-
tration in the cytoplasm for interaction or that additional in-
tranuclear factors are required for xHsl7–Wee1 binding. Con-
sistent with these data, xHsl7 and Wee1 did not interact in
mitotic extracts of 
 
Xenopus
 
 eggs where there is no nuclear
compartmentalization (Fig. 6 F).
Figure 6. Hsl7 promotes intranuclear Wee1 degradation. (A) Xenopus
stage VI oocytes were injected with 40 ng of  -globin or FLAG-xHsl7 mRNAs
and incubated in the presence of 50  M roscovitine. 12 h later, they were
injected again with 
35S-labeled Wee1 protein. After the second injection,
they were treated with progesterone (1  M) and roscovitine in modified
Barth’s   Ca buffer. At the indicated times after treatment, five oocytes
were manually dissected into nuclear (left) and cytoplasmic (right) fractions,
and analyzed by SDS-PAGE and autoradiography. The graph represents a
quantitation of the data above showing the fraction of Wee1 remaining in
nuclei or cytosol. Square,  -globin; circle, FLAG-xHsl7 mRNA injection. The
bars to the left of the panel denote the mobility shift of Wee1. (B) 40 ng
mRNAs of FLAG-xHsl7 (circle) and FLAG-xHsl7 metyltransferase mutant
(triangle) were injected into oocytes. The Wee1 degradation assay was
performed as described in panel A. The graph shows the fraction of Wee1
remaining in nuclei. (C) Oocytes were injected as in panel A, but after the
second injection, they were treated with leptomycin B (200 nM) for 2 h.
Progesterone (1  M) was then added to induce oocyte maturation. At the
indicated times after progesterone treatment, five oocytes were manually
fractionated and analyzed by SDS-PAGE followed by autoradiography.
The graph shows the fraction of Wee1 remaining in nuclei. Square,  -globin;
circle, FLAG-xHsl7 mRNA injection. (D) The experiment in Fig. 5 A was re-
peated as described except that MG132 was injected into the oocytes along
with the indicated mRNAs. Open square,  -globin; open circle, FLAG-
xHsl7; closed square, HA-Wee1 mRNA injection; closed circle, FLAG-xHsl7
and HA-Wee1 mRNAs coinjection. (E) Buffer (lane 1) or HA-Wee1 mRNA
(lanes 2 and 3) were incubated in cycling extracts in the presence (lanes 1
and 3) or absence (lane 2) of sperm chromatin. After 60 min, HA-Wee1
protein was isolated with anti-HA beads and bound proteins were analyzed
by anti-Hsl7 immunoblotting. (F) Interphase (lanes 1 and 3) or mitotic (lane
2) egg extracts were incubated in the presence of sperm chromatin for 60
min, and immunoprecipitated with anti-Wee1 antibody (lanes 1 and 2) or
control antibody (lane 3) bound to protein A–Sepharose beads. Immuno-
precipitates were then blotted with anti-Hsl7 antibodies. 
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Hsl7 overexpression overrides the DNA 
replication checkpoint
 
In 
 
S. cerevisiae
 
, inhibition of budding or actin depolymeriza-
tion triggers the morphogenesis checkpoint to prevent Hsl7-
stimulated Swe1 degradation (McMillan et al., 1999). Accord-
ingly, overexpression of Hsl7 will override the morphogenesis
checkpoint. Using similar logic, it was attractive to speculate
that overexpression of xHsl7 might override the DNA replica-
tion checkpoint as this has been reported to promote stabiliza-
tion of nuclear Wee1. To test this, we added excess xHsl7
mRNA to cycling extracts supplemented with nuclei and the
DNA polymerase inhibitor, aphidicolin, and monitored activa-
tion of Cdc2–cyclin B1-catalyzed histone H1 kinase activity.
Remarkably, excess xHsl7 abrogated G2/M arrest by the
checkpoint, allowing the efficient activation of Cdc2–cyclin B
and entry into mitosis even when DNA synthesis was inhibited
(Fig. 7 A).
Although the above data suggested that replication check-
point pathways might normally inhibit xHsl7 function, we
wished to obtain direct evidence that xHsl7–Wee1 interactions
could be modulated by the checkpoint. For this purpose, cy-
cling egg extracts containing sperm nuclei were incubated with
HA-tagged Wee1-encoding mRNA in the presence or absence
of aphidicolin to activate the replication checkpoint. Sodium
orthovanadate was also added to prevent Cdc25 activation and
consequent mitotic entry. After 60 min of room temperature
incubation (to allow the control nuclei to complete replication
and thus stop generating a checkpoint signal), the tagged Wee1
was immunoprecipitated with anti-HA antibodies and pre-
cipitates were immunoblotted with anti-Hsl7 antisera to de-
tect bound endogenous xHsl7. As shown in Fig. 7 B, activation
of the checkpoint completely disrupted xHsl7–Wee1 interac-
tions, strongly suggesting that the DNA replication check-
point stabilizes Wee1, at least in part, by inhibiting xHsl7–
Wee1 interactions.
 
Plx regulates the xHsl7–Wee1 
interaction
 
DNA responsive checkpoints are known to inhibit the Polo-like
kinase (Plk1; Smits et al., 2000; van Vugt et al., 2001; Deming
et al., 2002) and the Plk1 homologue Cdc5 interacts genetically
with yeast Swe1 (Bartholomew et al., 2001). Moreover, Cdc5
can phosphorylate Swe1 (Sakchaisri et al., 2004), and it was re-
cently found that SCF
 
 
 
-TrCP
 
 recognition of human Wee1 re-
quires Plk1-mediated phosphorylation (Watanabe et al., 2004).
Therefore, we sought to determine if checkpoint signaling
through 
 
Xenopus
 
 Polo-like kinase  (Plx1) might impact the
xHsl7–Wee1 interaction. Remarkably, when we supplemented
 
Xenopus
 
 egg extracts with a constitutively active Plx1 kinase
(Qian et al., 1999), xHsl7–Wee1 interactions that were abro-
gated by the DNA replication checkpoint were restored even in
the continued presence of aphidicolin to maintain a replication
arrest  (Fig. 7 C). These data strongly suggest that inhibiting
Plx1 function is important for stabilizing Wee1 and that the
ability of the DNA replication checkpoint to inhibit Plx1 feeds
into control of Wee1 stability, at least in part, by modulating
the xHsl7–Wee1 complex.
 
Discussion
 
As an inhibitor of Cdc2–cyclin B activation, the Wee1 kinase is
critical for determining the timing of entry into mitosis. Al-
though the catalytic activity of Wee1 can be controlled by vari-
ous upstream factors (e.g., 14–3-3 binding, Chk1 phosphoryla-
tion; Lee et al., 2001), recent reports indicate that Wee1 is also
regulated at the level of protein stability. In particular, it has
been demonstrated that DNA-responsive checkpoints can act to
stabilize the Wee1 protein (Michael and Newport, 1998),
thereby ensuring the continued suppression of Cdc2–cyclin B
until DNA replication is completed or DNA damage is re-
paired. In this study we have shown that the 
 
Xenopus
 
 Hsl7 pro-
tein acts upstream of Wee1 to control its intranuclear stability.
Figure 7. Excess Hsl7 overrides the DNA replication checkpoint. (A) Xenopus
Hsl7 or  -globin mRNA was incubated in cycling extracts in the presence
of aphidicolin (200  g/ml). Cell cycle progression was monitored by
assessing histone H1 kinase activity. Square,  -globin mRNA; circle, FLAG-
xHsl7 mRNA. An arrow indicates the time of the nuclear envelope break
down and the chromosome condensation as monitored by a microscope.
(B) Buffer (lane 1) or HA-Wee1 mRNA (lanes 2,3, 4) were incubated in
cycling extracts containing no sperm (lane 2) or sperm chromatin DNA
(lanes 1, 3, and 4) in the absence (lanes 1–3) or presence (lane 4) of
aphidicolin (200  g/ml). After a 60-min incubation, HA-Wee1 protein
was isolated with anti-HA beads and bound proteins were analyzed by
anti-Hsl7 immunoblotting. (C) Buffer (lane 1) or HA-Wee1 mRNA (lanes 2–4)
were incubated in cycling extracts containing sperm chromatin DNA in the
absence (lanes 1 and 2) or presence (lanes 3 and 4) of aphidicolin (200
 g/ml) and inactive Plx1 (lane 3) or constitutively active Plx1 (T201D; lane
4). After a 60-min incubation, HA-Wee1 protein was isolated with anti-HA
beads and bound proteins were analyzed by anti-Hsl7 immunoblotting. 
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Accordingly, inactivation of xHsl7 was able to slow mitotic en-
try, although its overexpression accelerated the onset of M
phase, even in the presence of unreplicated DNA. These data
position 
 
Xenopus
 
 Hsl7 as a novel vertebrate regulator of mi-
totic entry and suggest that xHsl7 may play an important role in
transducing DNA-responsive checkpoint signals.
 
Hsl7 and the control of nuclear Wee1 
stability
 
The ability of xHsl7 to accelerate mitotic entry in egg extracts
only in the presence of nuclei is consistent with previous reports
suggesting that Wee1 degradation is an intranuclearlycontrolled
event. Indeed, we also found that overexpression of xHsl7 in
oocytes had no effect on M phase entry unless Wee1 was
present and this effect was apparently exerted at the level of nu-
clear Wee1 stability. There are a number of possible explana-
tions for this nuclear requirement. First, it may be that xHsl7
and Wee1 only achieve sufficient concentration for binding
when both are present within nuclei. Consistent with this idea,
we observed a strong interaction between these proteins only in
the presence of nuclei. It is also possible that a specific nuclear
structure serves to promote their colocalization and interaction.
For example, modulation of xHsl7–Wee1 interactions in re-
sponse to the DNA replication checkpoint may reflect a direct
effect of replication structures on xHsl7–Wee1 binding. It is
also possible that the effect of nuclei reflects a requirement for
specific nuclearly localized cofactors in Wee1 degradation. For
example, we note that both Wee1 and xHsl7 appear to be phos-
phorylated just before the disappearance of Wee1. It may be
that nuclear kinases contribute to Wee1 degradation.
Our data suggest that Plx1 can facilitate Wee1 degradation
by promoting xHsl7–Wee1 interactions. Moreover, the reported
down-regulation of polo-like kinases by DNA-responsive check-
points could potentially lead to stabilization of Wee1 by prevent-
ing efficient xHsl7–Wee1 binding. Recently, it was reported that
Plk1 can stimulate interactions between human Wee1 and
 
 
 
-TrCP through phosphorylation of Wee1 (Watanabe et al., 2004).
One intriguing possibility is that the Plx1 stimulation of xHsl7–
Wee1 interactions leads to enhanced interactions of Wee1 with
SCF E3 ubiquitin ligases. Although this issue merits further in-
vestigation, we have observed only weak (potentially nonspe-
cific) interactions between 
 
Xenopus
 
 Wee1 and its two reported
F-box interactors (
 
 
 
-TrCP and Tome1) and these interactions do
not appear to be markedly altered by either xHsl7 overexpression
or depletion. With regard to 
 
 
 
-TrCP interactions, it is worth not-
ing that the Plk1 phosphorylation site on the somatic human
Wee1A (S53) that has been implicated in Wee1 degradation is
not conserved in 
 
Xenopus
 
 Wee1 (Watanabe et al., 2004). Thus,
further evaluation of Plx1 involvement in promoting xHsl7–
Wee1 binding and Wee1 degradation will require identification
of sites phosphorylated by Plx1 on 
 
Xenopus
 
 Wee1. As prelimi-
nary in vitro kinase assays using purified Plx and Wee1 proteins
suggest that there are likely to be multiple sites of Plx1 phos-
phorylation on 
 
Xenopus
 
 Wee1  (unpublished data), it may re-
quire extensive mutagenesis to identify sites relevant for promot-
ing Wee1 degradation (note the presence of at least 20 Cdc5 sites
on 
 
S. cerevisiae
 
 Swe1; Sakchaisri et al., 2004).
With regard to the role of phosphorylation in promoting
xHsl7–Wee1 interactions, it is also of interest that one of the
key regulators of Swe1 stability in yeast is an Hsl7-interacting
kinase, Hsl1 (McMillan et al., 1999; Cid et al., 2001). A true
vertebrate Hsl1 has not yet been identified, in part because
Hsl1 is a member of a large class of protein kinases, most of
which do not function in cell cycle control, and the conserva-
tion between Hsl1-like proteins in different species is too low
to allow definitive identification of a vertebrate ortholog by se-
quence analysis. It may soon be possible, however, to identify
such a protein through interaction with our 
 
Xenopus
 
 Hsl7
clone.
 
Multiple roles for Hsl7
Hsl7 homologues have been reported to have different roles in
different species (Gilbreth et al., 1998; McMillan et al., 1999;
Pollack et al., 1999; Shulewitz et al., 1999; Yang et al., 1999;
Ma, 2000; Bao et al., 2001; Friesen et al., 2001; Meister et al.,
2001). For example, unlike in S. cerevisiae where Hsl7 has
been shown to regulate Swe1 stability (McMillan et al., 1999),
the S. pombe Hsl7 has been reported to inhibit Cdc2 through di-
rect binding (Gilbreth et al., 1998). We have been unable to de-
tect any such direct interactions between xHsl7 and Cdc2 in
Xenopus (unpublished data). Because the vertebrate cell cycle
shares with S. pombe the use of Cdc2 tyrosine phosphorylation
to control both the timing of unperturbed mitotic entry and cell
cycle delay in response to DNA checkpoints (Rhind and Rus-
sell, 1998; Norbury et al., 1991), it is perhaps surprising that
xHsl7 function is more akin to that of its S. cerevisiae homo-
logue, where DNA responsive checkpoints do not promote a
specific G2 arrest. With regard to vertebrate Hsl7, we note that
it has been reported that the human homologue, JBP1, can
complement an S. cerevisiae Hsl7 mutation (Lee et al., 2000).
Moreover, at the start of this work we found that S. cerevisiae
Hsl7 can interact physically with Xenopus Wee1.
In both S. cerevisiae and in our own experiments in Xeno-
pus, it appears that residues critical for Hsl7 methyltransferase
activity are dispensable for the cell cycle effects of Hsl7
(Theesfeld et al., 2003). These data suggest that Hsl7 functions
in at least two modes—as a cell cycle regulator (perhaps
through direct binding of its targets or recruitment of other fac-
tors to its targets) and as a methyltransferase involved in dis-
tinct biological processes. In this regard, it has been reported
that the S. pombe Hsl7 homologue is a mediator of hyperos-
motic stress whose methyltransferase activity is stimulated un-
der stressor conditions and in human cells, JBP1 can interact
with Jak family kinases, presumably to control transcription
(Pollack et al., 1999; Bao et al., 2001). In addition, the human
20S methylosome that methylates Sm proteins before assembly
into SnRNP core particles contains Hsl7 as a catalytic subunit
(Friesen et al., 2001; Meister et al., 2001). Our data showing
that xHsl7 can affect cell cycle progression in the transcription-
ally inactive Xenopus egg extract further strengthens the idea
that the effects of xHsl7 on RNA transcription/processing are
very likely to be distinct from its cell cycle effects. Addition-
ally, xHsl7 methyltransferase activity is likely to be more im-
portant for the former than the latter.JCB • VOLUME 167 • NUMBER 5 • 2004 848
Hsl7–Wee1 as a checkpoint control 
module
In budding yeast, degradation of Swe1 involves the hierarchi-
cal association of Hsl1, then Hsl7, then Swe1 to the mother/bud
neck (Shulewitz et al., 1999; Longtine et al., 2000). When bud-
ding is prevented, the morphogenesis checkpoint is activated,
leading to inactivation of the Hsl1–Hsl7–Swe1 cell cycle con-
trol module and consequent stabilization of Swe1 (McMillan et
al., 1999). This is accomplished, at least in part, by impairing
proper recruitment of Hsl7 to the septin cortex. Although these
specifics of Swe1 degradation are obviously not directly appli-
cable to Wee1 degradation in animal cells that do not repro-
duce by budding, our data indicate that Hsl7 can also be used to
control Wee1 stability in vertebrates. In effect, these data dem-
onstrate that cell cycle control “modules” can be co-opted for
use by different checkpoint signaling pathways. In S. cerevi-
siae, Hsl7 does, indeed, regulate Swe1 stability, but this regula-
tory module is under the control of pathways responding to
perturbations in morphogenesis. In vertebrate cells, control of
Wee1 stability is important for the operation of DNA-respon-
sive checkpoints that operate to control the state of Cdc2 tyro-
sine phosphorylation.
Materials and methods
Cloning of Xenopus Hsl7 cDNA
Using the protein sequence of the human Hsl7 homologue, JBP1, in a BLAST
search against the Washington University Xenopus EST database we identi-
fied 5 EST clones homologous to JBP1. After sequencing, it was determined
that the EST clone with GenBank/EMBL/DDBJ accession number BF613396
contained the full-length Xenopus homologue of JBP1, xHsl7.
Plasmid construction and RNA synthesis
GST-xHsl7 was constructed by inserting the Xenopus EST clone into the
BglII and HindIII sites of pGEX’KG, resulting in addition of nine amino ac-
ids to the linker between GST and xHsl7. FLAG-xHsl7 was amplified by
PCR using FLAG-xHsl7/BglII (5 -TTT AGA TCT ATG GAC TAC AAG GAC
GAC GAT GAC AAG ATG GCG GCA GGT G-3 ) and xHsl7/NotI (5 -
TTG CGG CCG CAA TCA CAG GCC AAT TG-3 ). The amplified frag-
ment was digested with BglII and NotI and subcloned into pSP64T, yield-
ing pSP64T/FLAG-xHsl7. The metyltransferase mutant of xHsl7 (Arg364
to Ala) was made using the Quick Change Site-Directed Mutagensis Kit
(Stratagene); the primers used were 5 -GTG CTC GGA GCA GGC GCG
GGA CCC CTT-3  and 5 -AAG GGG TCC CGC GCC TGC TCC GAG
CAC-3 . To prepare pSP64T/HA-Wee1, Wee1 was PCR amplified using
xWee1/BglII (5 -AAG GTG AGA TCT ATG AGA ATG GCC-3 ) and
xWee1/NotI (5 -TTG CGG CCG CAA TTA ATA CCC TCC GC-3 ). The
PCR fragment was digested with BglII and NotI, and subcloned into pEBB-
HA vector. Then, HA-Wee1 was amplified again by PCR using HA/
BamHI (5 -CTT GGA TCC ATG GCT TCT AGC TAT CCT TAT GAC-3 ) and
xWee1/NotI, digested with BamHI and NotI, and subcloned into pSP64T.
Constructs were digested with XbaI and mRNAs prepared using Strat-
agene’s mCAP RNA capping kit.
Purification of recombinant xHsl7 and Plx1
GST-xHsl7 in BL21 E. coli. was grown to an OD600 of 0.5 at 37 C. It was
then transferred to 18 C and grown to an OD600 of 0.8 and induced with
50  l 0.5 M isopropyl-1-thio- -D-galactopyranoside per liter for 18 h. Pro-
teins were prepared as in Walsh et al. (2003). To obtain cleaved xHsl7,
GST-xHsl7 beads were washed twice and incubated with 500  l of throm-
bin cleavage buffer (20 mM Tris, pH 8.4, 150 mM NaCl, and 2.5 mM
CaCl2) with 10 U thrombin for 1 h at room temp. Cleaved protein was di-
alyzed into XB buffer (100 mM KCl, 50 mM sucrose, 10 mM Hepes, pH
7.7, 1 mM MgCl2, and 0.1 mM CaCl2). For binding assay of GST-xHsl7
and Wee1 protein, GST-xHsl7 or GST beads were washed twice with egg
lysis buffer (ELB; pH 7.7; 250 mM sucrose, 50 mM KCl, 10 mM Hepes,
2.5 mM MgCl2, and 1 mM DTT) and then incubated with interphase egg
extract for 1 h at 4 C. The beads were washed five times in ELB and
bound proteins were eluted with SDS-PAGE sample buffer, resolved by
SDS-PAGE and blotted with anti-Wee1 (Zymed Laboratories). Plx1 and
constitutively active Plx1 (T201D) were purified as described previously
(Qian et al., 1998). GST-Hsl7 (yeast) was a gift from the lab of Daniel
Lew (Duke University, Durham, NC).
Xenopus egg extract and immunodepletion of Hsl7
Xenopus egg extracts (cycling, interphase [S], and ultra S) and sperm
chromatin were prepared as described previously (Murray, 1991). For im-
munodepletion of xHsl7 from egg extract, 10  g of anti-JBP1(Hsl7) or con-
trol mouse IgG1 (Abcam) was bound to 40  l of a 1:1 mixture of protein
A–Sepharose 4B beads and Sepharose 4B rat anti–mouse IgG1 beads
and then washed twice with egg lysis buffer. These beads were then incu-
bated under constant agitation with 100  l of egg extract for 30 min at
4 C. The depletion procedure was then repeated with a new set of beads
to allow for maximal depletion.
Histone H1 kinase assay
2  l of cycling extracts was added to 28  l of H1 kinase reaction mix
(final concentrations, 10 mM Hepes KOH [pH 7.2], 5 mM MgCl2, 50
mM NaCl, 83  M ATP, 4.2 mM DTT, 5  g of histone H1) and 2  Ci
[ -
32P]ATP. The reactions were incubated at room temperature for 10 min
and resolved by 12.5% SDS-PAGE. The bands corresponding to histone
H1 were quantified with a phosphorimager (Molecular Dynamics).
Oocyte injection and Wee1 degradation assay
Stage VI oocytes were prepared as described previously (Swenson et al.,
1989). 40 nl of mRNAs (40 ng) encoding  -globin or FLAG-xHsl7 were
injected into oocytes. Injected oocytes were incubated in 50  M rosco-
vitine. After 12 h, they were injected with 40 nl of 
35S-labeled in vitro–
translated Wee1 and treated with 1  M progesterone and roscovitine in
modified Barth’s   Ca buffer. Five oocytes were separated into nuclear
and cytoplasmic fractions by manual dissection under mineral oil. Nuclei
were resuspended in SDS-PAGE sample buffer. Cytoplasmic fractions
were suspended in buffer (20 mM Hepes KOH, pH 7.5, 20 mM  -glyc-
erophosphate, 15 mM MgCl2, 20 mM EGTA, 1 mM PMSF, and 5 ng/ l
aprotinin/leupeptin) and spun for 5 min at 13,000 g to remove insoluble
material. The fractions were separated on 10% SDS-PAGE and the re-
maining Wee1 in these fractions was quantified by phosphorimager.
Co-immunoprecipitation of xHsl7 and Wee1
For co-immunoprecipitation of Wee1 and xHsl7 in interphase extracts, 10
 g anti-Wee1 or control rabbit IgG was bound to 20  l of protein
A–Sepharose 4B beads, washed twice with ELB, and then incubated with
interphase egg extract for 1 h at 4 C. Beads were then washed three times
with ELB, eluted with SDS-PAGE sample buffer, resolved by SDS-PAGE,
and blotted with anti-JBP1 (BD Biosciences). For co-immunoprecipitation of
xHsl7 and Wee1 in cycling extracts, 7.5  g of HA-Wee1 mRNA was
added to 150  l of extract with or without 5,000/ l sperm chromatin and
0.5 mM Na3VO4 and incubated at room temperature for 60 min. In some
cases, 0.2 mg/ml aphidicolin was added. Extracts were then diluted with
buffer (10 mM Hepes KOH, pH 7.5, 0.1 M KCl, 0.1% Nonidet P-40, and
10 mM  -glycerophosphate) and incubated with 20  l of anti-HA affinity
matrix (Roche) at 4 C. After 2 h, beads were washed twice and eluted
with SDS-PAGE sample buffer. Bound fractions were subjected to SDS-
PAGE followed by anti-JBP1 immunoblotting.
Cdc2 Tyr15 phosphorylation
To measure the effect of Hsl7 on Cdc2 tyrosine 15 phosphorylation rates,
100  l aliquots of egg were either depleted with anti-JBP1 sera or with
preimmune sera. In addition, 100  l aliquots of cytosol were supple-
mented with 10  l of XB buffer or 10  l of recombinant xHsl7 in XB
buffer. Samples were incubated for 10 min at 4 C with an ATP-regenerat-
ing system with or without 0.5 mM Na3VO4. Kinase assays were initiated
by addition of 1  l of cyclin B1 13 and proceeded for 10 min be-
fore SDS-PAGE sample buffer addition. 2  l of each sample was then re-
solved by SDS-PAGE and blotted with anti-phospho–Cdc2 (Cell Signaling
Technology).
Microscopy
DNA was stained with Hoechst 33258 and nuclear morphology was ex-
amined using a Zeiss Axioskop with a 40  Plan-Neofluar air objective
with an NA of 0.75. Images were captured using a Pentamax cooled
charge-coupled device camera (Princeton Instruments), interfaced with
MetaMorph software (Universal Imaging Corp.) and levels were adjusted
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